Bruce Colwill - Net Worth and Insider Trading
Bruce Colwill Net Worth
The estimated net worth of Bruce Colwill is at least $119 dollars as of 2024-11-13. Bruce Colwill is the CFO of InMed Pharmaceuticals Inc and owns about 461 shares of InMed Pharmaceuticals Inc (INM) stock worth over $119. Details can be seen in Bruce Colwill's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Bruce Colwill has not made any transactions after 2022-01-24 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Bruce Colwill
Bruce Colwill Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Bruce Colwill owns 1 companies in total, including InMed Pharmaceuticals Inc (INM) .
Click here to see the complete history of Bruce Colwill’s form 4 insider trades.
Insider Ownership Summary of Bruce Colwill
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| INM | InMed Pharmaceuticals Inc | 2022-01-24 | CFO |
Bruce Colwill Latest Holdings Summary
Bruce Colwill currently owns a total of 1 stock. Bruce Colwill owns 461 shares of InMed Pharmaceuticals Inc (INM) as of January 24, 2022, with a value of $119.
Latest Holdings of Bruce Colwill
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| INM | InMed Pharmaceuticals Inc | 2022-01-24 | 461 | 0.26 | 119 |
Holding Weightings of Bruce Colwill
Bruce Colwill Form 4 Trading Tracker
According to the SEC Form 4 filings, Bruce Colwill has made a total of 2 transactions in InMed Pharmaceuticals Inc (INM) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in InMed Pharmaceuticals Inc is the acquisition of 200 shares on January 24, 2022, which cost Bruce Colwill around $5,450.
Insider Trading History of Bruce Colwill
- 1
Bruce Colwill Trading Performance
GuruFocus tracks the stock performance after each of Bruce Colwill's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Bruce Colwill is -24.77%. GuruFocus also compares Bruce Colwill's trading performance to market benchmark return within the same time period. The performance of stocks bought by Bruce Colwill within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Bruce Colwill's insider trading performs compared to the benchmark.
Performance of Bruce Colwill
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -15.02 | | | | | |
| Relative Return to S&P 500(%) | -16.45 | | | | | |
Bruce Colwill Ownership Network
Ownership Network List of Bruce Colwill
Ownership Network Relation of Bruce Colwill
Bruce Colwill Owned Company Details
What does InMed Pharmaceuticals Inc do?
Who are the key executives at InMed Pharmaceuticals Inc?
Bruce Colwill is the CFO of InMed Pharmaceuticals Inc. Other key executives at InMed Pharmaceuticals Inc include Sr VP & Clinical Reg Affairs Mancini Alexandra Diane Janet , director & President & CEO Eric A Adams , and Interim CFO Jonathan Tegge .
InMed Pharmaceuticals Inc (INM) Insider Trades Summary
Over the past 18 months, Bruce Colwill made no insider transaction in InMed Pharmaceuticals Inc (INM). Other recent insider transactions involving InMed Pharmaceuticals Inc (INM) include a net purchase of 41,600 shares made by Eric A Adams , a net purchase of 37,500 shares made by Andrew Hull , and a net sale of 240 shares made by Mancini Alexandra Diane Janet .
In summary, during the past 3 months, insiders sold 0 shares of InMed Pharmaceuticals Inc (INM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 240 shares of InMed Pharmaceuticals Inc (INM) were sold and 79,100 shares were bought by its insiders, resulting in a net purchase of 78,860 shares.
InMed Pharmaceuticals Inc (INM)'s detailed insider trading history can be found in Insider Trading Tracker table.
InMed Pharmaceuticals Inc Insider Transactions
Bruce Colwill Mailing Address
Above is the net worth, insider trading, and ownership report for Bruce Colwill. You might contact Bruce Colwill via mailing address: C/o Inmed Pharmaceuticals Inc., Suite 310 - 815 Hastings Street, Vancouver A1 V6c 1b4.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
